PN-202-791;4-Isopropyl-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-3-pyridinecarboxylate;Isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-3-pyridinecarboxylate;propan-2-yl (4S)-2,6-dimethyl-5-nitro-4-(8-oxa-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-2-yl)-1,4-dihydropyridine-3-carboxylate;PN 202-791;Pyridinecarboxylic acid, 4-(1,3-dihydro-4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-5-nitro-, 1-methylethyl ester, (S)-; 

Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2 g1-chain anti-human p185c-erbB2receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain,dimer; Trastuzumab;Immunoglobulin G1,anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 g1-chain), disulfide with human-mousemonoclonal rhuMab HER2 light chain, dimer;Herceptin; rhumAb 4D5;